Variants in the ASB10 Gene Are Associated with Primary Open Angle Glaucoma by Micheal, S. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/152920
 
 
 
Please be advised that this information was generated on 2017-12-05 and may be subject to
change.
RESEARCH ARTICLE
Variants in the ASB10 Gene Are Associated
with Primary Open Angle Glaucoma
Shazia Micheal1, Humaira Ayub1,2, Farrah Islam3, Sorath Noorani Siddiqui3, Wajid
Ali Khan3, Farah Akhtar3, Raheel Qamar2,4, Muhammad Imran Khan5, Anneke I.
den Hollander1,5*
1 Department of Ophthalmology, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands,
2 Department of Biosciences, COMSATS Institute of Information Technology, Islamabad, Pakistan, 3 Al-
Shifa Eye Trust Hospital Jhelum Road, Rawalpindi, 46000, Pakistan, 4 Al-Nafees Medical College &
Hospital, Isra University, Islamabad, 45600, Pakistan, 5 Department of Human Genetics, Radboud
University Nijmegen Medical Centre, Nijmegen, the Netherlands
* Anneke.denHollander@radboudumc.nl
Abstract
Background
Recently nonsynonymous coding variants in the ankyrin repeats and suppressor of cytokine
signaling box-containing protein 10 (ASB10) gene were found to be associated with primary
open angle glaucoma (POAG) in cohorts from Oregon and Germany, but this finding was
not confirmed in an independent cohort from Iowa. The aim of the current study was to
assess the role of ASB10 gene variants in Pakistani glaucoma patients.
Methods
Sanger sequencing of the coding exons and splice junctions of the ASB10 gene was per-
formed in 30 probands of multiplex POAG families, 208 sporadic POAG patients and 151
healthy controls from Pakistan. Genotypic associations of individual variants with POAG
were analyzed with the Fisher’s exact or Chi-square test.
Results
In total 24 variants were identified in POAG probands and sporadic patients, including 11
novel variants and 13 known variants. 13 of the variants were nonsynonymous, 6 were syn-
onymous, and 5 were intronic. Three nonsynonymous variants (p.Arg49Cys, p.Arg237Gly,
p.Arg453Cys) identified in the probands were not segregating in the respective families.
This is not surprising since glaucoma is a multifactorial disease, and multiple factors are
likely to be involved in the disease manifestation in these families. However a nonsynon-
ymous variant, p.Arg453Cys (rs3800791), was found in 6 sporadic POAG patients but not
in controls, suggesting that it infers increased risk for the disease. In addition, one synony-
mous variant was found to be associated with sporadic POAG: p.Ala290Ala and the associ-
ation of the variant with POAG remained significant after correction for multiple testing
(uncorrected p-value 0.002, corrected p-value 0.047). The cumulative burden of rare,
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nonsynonymous variants was significantly higher in sporadic POAG patients compared to
control individuals (p-value 0.000006).
Conclusions
Variants in ASB10 were found to be significantly associated with sporadic POAG in the
Pakistani population. This supports previous findings that sequence variants in the ASB10
gene may act as a risk factor for glaucoma.
Introduction
Glaucoma is a group of heterogeneous optic neuropathies and a leading cause of irreversible
blindness, affecting approximately 70 million individuals worldwide [1, 2]. One of the major
risk factors for glaucoma is an abnormal elevation of intraocular pressure (IOP). Glaucoma
causes an irreversible destruction of the optic nerve, which ultimately affects the central visual
pathway. This involves the degeneration and death of the retinal ganglion cells, which leads to
a progressive deterioration of the visual field [3].
The cellular and molecular mechanisms underlying glaucoma are not yet fully understood.
Family-based linkage analysis and case-control studies have shown that genetic variants con-
tribute to the pathogenesis of POAG [4–8]. At least 16 chromosomal loci for POAG have been
reported [4–6]. To date, several causative genes and 16 POAG-associated loci have been identi-
fied, including myocilin (MYOC/GLC1A; MIM 601652) [7, 8], optineurin (OPTN/GLC1E;
MIM 137760) [9], WD repeat domain 36 (WDR36/GLC1G; MIM 609669) [10, 6], cytochrome
P450 1B1 (CYP1B1; MIM 231300) [11,12]. In addition, genome-wide association studies have
detected several POAG-associated gene variants, some potentially acting at the level of the tra-
becular meshwork (associated with elevated IOP), and others possibly at the level of the retinal
ganglion cells [13–16].
Recently, ankyrin repeats and suppressor of cytokine signalling (SOCS) box-containing pro-
tein 10 (ASB10) has been identified as a novel POAG candidate gene (MIM 603383) located at
chromosome 7q35–q36, the GLC1F locus. Further support was provided by the additional
screening of the POAG patients from Oregon and Germany [17], but this was not confirmed
in an independent POAG cohort from Iowa [18]. In the current study we further investigated
the role of the ASB10 gene in glaucoma families and sporadic POAG patients from Pakistan.
Materials and Methods
Subjects
Thirty families with juvenile- and adult-onset POAG (age range 16–60 years), 208 sporadic
Pakistani POAG patients with a mean age of 55.3±1.2 years (51% male and 49% female), and
151 healthy controls with a mean age of 53.7±1.1 years (53% male, 47% female) were included
in this study. Probands of all the families included in the current study were excluded for the
variants in the CYP1B1,MYOC, OPTN,WDR36 genes.
Ethics statement
The study adhered to the guidelines of the Declaration of Helsinki and was approved by the
Institutional Review Board of Al-Shifa Eye Trust Hospital. After signed informed consents
were obtained, blood samples were collected for DNA isolation.
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Clinical evaluations
Complete ophthalmic examinations were performed for patients and controls. Juvenile-onset
POAG was diagnosed between age 3 years and early adulthood (<35 years). Adult-onset
POAG was diagnosed at adulthood, usually after 35 years of age. Briefly, for POAG patients
the inclusion criteria were high IOP (>21 mmHg) measured using Goldmann applanation
tonometry, a cup-to-disc ratio (CDR)>0.7 with thinning or notching of the disc rim [19], and
visual field defects. Visual field defects typical of glaucoma such as arcuate scotoma, nasal step
and paracentral scotoma were determined with a Humphrey Field Analyzer (Zeiss Humphrey
Systems, Dublin, CA, USA), and an open anterior chamber angle was confirmed with gonio-
scopy. Although high IOP is not part of the definition of glaucoma, we used strict criteria to
exclude other types of glaucoma in our cohort. Controls and cases were matched for age, gen-
der and ethnicity. The same detailed ophthalmological examinations were done for the controls
as for the glaucoma patients, and only control individuals without glaucoma were selected.
DNA isolation and genetic analysis
A conventional phenol-chloroform method was used for the extraction of genomic DNA from
whole blood [20]. Primers flanking the entire coding sequence of ASB10 were designed with
Primer3 software (primer sequences and PCR conditions are available on request). The ampli-
fied region covered at least 50 base pairs into each intron to screen for potential mutations
affecting splicing. PCR products were visualized on 2% agarose gel and purified with PCR
clean-up purification plates (NucleoFast1 96 PCR, MACHEREY-NAGEL, Germany), accord-
ing to the manufacturer’s protocol. Purified PCR products were analyzed by Sanger sequencing
in an automated DNA sequencer (Big Dye Terminator, version 3 on a 3730 DNA analyzer;
Applied Biosystems, Inc., Foster City, CA). Sequencing results were aligned with the reference
sequence (obtained from the hg19 human genome build) and analyzed using Vector NTI
Advance (TM) 2011 software (Invitrogen).
In silico analysis
In addition, the pathogenicity of ASB10missense variants was evaluated by publically available
tools including PhyloP, Grantham, PolyPhen2, and SIFT [21]. Evolutionary conservation was
determined for variants which were predicted pathogenic by PolyPhen2 and SIFT, or had a
high Grantham distance or PhlyoP score. To assess the amino acid conservation, orthologous
ASB10 protein sequences of various species were aligned using Vector NTI Advance (TM)
2011 software. The amino acid sequences were obtained from protein sequence database Uni-
Prot (http://www.uniprot.org).
Statistical analysis
The genotype frequency of individual sequence variants in the ASB10 gene was compared
between sporadic POAG patients and control individuals using a Fisher’s exact test for rare
variants (n<5), and a Chi-square test for common variants. P-value0.002 was considered
significant after correction for multiple testing (α/number of variants) [22], (https://www.
easycalculation.com/statistics/bonferroni-correction-calculator.php).
Results
Analysis of the ASB10 gene in 30 probands (one per family) of Pakistani glaucoma families
revealed six nonsynonymous, two synonymous, and two intronic variants (Tables 1 and 2).
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Of these variants, three nonsynonymous variants (p.Arg49Cys, p.Arg237Gly, p.Arg453Cys)
were not detected in control individuals (Table 1). However, none of the variants segregate
with the disease in the family members of the probands (Fig 1). However individual III:2, who
is homozygous for the pArg453Cys variant, has a more severe phenotype compared to his sibs.
He was diagnosed with bilateral glaucoma in the age of 15 years. He was subjected to two trabe-
culectomies to control the IOP of both eyes (right 42mmHg; left 38mmHg). The cup-to-disc
ratios of both eyes were also high (0.9). He lost the vision in both eyes at age 35, presenting
visual acuities of 20/25 and 20/60 with tubular visual fields (less than 10°). He still needs to use
prostaglandin analogs to lower his IOP.
Sequence analysis of the ASB10 gene was further extended to a Pakistani cohort of 208 spo-
radic POAG patients and 151 controls. In addition to the above mentioned variants, 14 addi-
tional variants were identified in sporadic POAG patients. Of these, seven variants were
nonsynonymous, 4 synonymous and 3 were intronic variants (Tables 1 and 2). Five nonsynon-
ymous variants (p.Val62Met, p.Gln295His, p.Arg296Gln, p.Arg304Cys, p.Arg447His) identi-
fied in POAG patients were not detected in control individuals. Conversely, no
nonsynonymous, synonymous and intronic variants were identified that are present in control
individuals but not in POAG patients.
Association of each individual nonsynonymous, synonymous and intronic variant with
POAG was assessed (Tables 1 and 2). One rare nonsynonymous variant (p.Arg453Cys) was
detected in 6 sporadic POAG patients, but not in control individuals (p [uncorrected] = 0.04).
However, this difference also did not remain significant after correction for multiple testing (p
[corrected] = 0.62). One common synonymous variant (p.Ala290Ala) was detected heterozy-
gously more frequently in POAG patients (49%) and probands (50%) compared to control
individuals (33%), and the difference in genotype frequencies remained significant after correc-
tion for multiple testing (p [uncorrected] = 0.002, p [corrected] = 0.047).
Fig 1. Pedigrees of consanguineous Pakistani glaucoma families, with a probable autosomal dominant inheritance pattern. Segregation analysis of
three nonsynonmous variants: (1A) represents segregation of p.Arg49Cys, (1B) segregation of p.Arg237Gly change, (1C) shows p.Arg453Cys variant
segregation, Variant allele is indicated with an “M1(p.Arg49Cys), M2(p.Arg237Gly) and M3(p.Arg453Cys)”, and the wildtype allele indicated with “WT” for the
three variations. This demonstrates that the variants do not segregate with the disease in the respective families. The proband is indicated with an arrow.
doi:10.1371/journal.pone.0145005.g001
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One variant (c.1218+42T>C) was found more frequently in control individuals than in
POAG patients but the frequencies of three genotypes in patients compared to controls shows
a trend towards association (p [uncorrected] = 0.04), suggesting it might have a protective role,
but this did not remain significant after correction for multiple testing (p [corrected] = 0.62).
Collectively, nonsynonymous variants were detected in 106/1468 (7.2%) patients, and in 18/
694 (2.6%) controls after excluding the common variants (c.1075 G>A, c.1114 C>T,
c.1204C>A). A significant difference in number of variants in patients compared to controls
was observed (p-value 0.000006) upon combing the number of patients and controls of the cur-
rent and previous two studies (Table 3).
Six of the 10 rare, nonsynonymous variants are predicted to be pathogenic by at least 2 path-
ogenicity prediction tools (p.Arg49Cys, p.Val62Met, p.Arg237Gly, p.Arg304Cys, p.Leu342Pro,
p.Arg447His) (Table 1). In addition, seven variants (p.Glu229Asp, p.Arg296Gln, p.Val359Ile,
p.Arg372Cys, p.Pro420Thr, p.Arg447His, p.Arg453Cys) affect amino acids that are highly con-
served during evolution (Fig 2).
Discussion
In a recent study, ASB10 was identified as a novel gene for glaucoma at the GLC1F locus. A
synonymous variant (c.765C>T; p.Thr255Thr) was identified in a large family with POAG,
which was found to segregate with the disease. Further support was provided by the identifica-
tion of ASB10 variants in POAG patients from Oregon and Germany [17]. A few additional
variants were identified in POAG patients from Iowa, but they were reported not to be signifi-
cantly associated with POAG [18]. In the current study 10 rare amino acid changes were identi-
fied in 23/238 (9.7%) patients (Table 1) compared to 2/151 (1.3%) of the population matched
controls (p-value 0.0005). Similarly in the study performed by Pasutto et al 70 patients were
identified with 26 (6.0%) rare amino acid changes compared to 9 amino acid changes in 13
controls (2.8%) (p-value 0.008). However, in the Iowa cohort 11 rare amino acid substitutions
were detected in 13/158 (8.2%) patients compared to 3/82 (3.7%) controls, and the difference
was not statistically significant (p-value 0.27). Taken together, the burden of rare amino acid
Fig 2. Amino acid conservation of amino acids of ASB10 in different species.Mutated amino acids conserved in humans and other species are shown
in blue color.
doi:10.1371/journal.pone.0145005.g002
Table 3. Burden test for rare nonsynonymous variants identified in POAG patients and controls in different cohorts.
Pakistan Iowa [19] Germany and US [18] Combined form 3 studies
Patient 23/238 (9.7%) 13/158 (8.2%) 70/1172 (6.0%) 106/1468 (7.2%)
Control 2/151 (1.3%) 3/82 (3.7%) 13/461 (2.8%) 18/694 (2.6%)
p-value 0.0005 0.27 0.008 0.000006
doi:10.1371/journal.pone.0145005.t003
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changes among all three cohorts, a significant association with POAG (p-value 0.000006) was
observed.
The synonymous variant p.Thr255Thr identified by Pasutto et al. [17] was not found in a
subsequent study from Iowa nor in the current study of Pakistani POAG patients. This suggests
that Thr255Thr is a rare variant that may be population- or region-specific. The Thr255Thr
was reported to affect an exonic splice enhancer, leading to aberrant splicing of the ASB10
transcript.
In the current study we detected a significant association of another synonymous variant
(c.870G>C; p.Ala290Ala), which was also reported previously in POAG patients from Ger-
many, Oregon and Iowa. In the Iowa cohort the p.Ala290Ala variant (labeled as p.Ala275Ala)
was also present at a higher frequency in POAG patients compared to controls with a margin-
ally significant p-value 0.05 [18]. In Pakistani POAG patients a similar frequency of the hetero-
zygous genotype (49%) was observed, and the frequency in controls (33%) was slightly lower
than in the Iowa cohort (p-value 0.01; OR 1.76 [95% CI 1.10–2.83]). However, in the German
cohort the frequency of the heterozygous genotype was higher in controls (57%) compared to
POAG patients (47%) [17]. Therefore, the significance of this association in the pathogenicity
of POAG is unclear.
Interestingly, both synonymous variants, p.Thr255Thr [17] and p.Ala290Ala, are located in
one of the ankyrin repeats. The ankyrin repeat structure and number is an important determi-
nant of the target substrate to which ASB10 protein is bound. Disruption of the repeat structure
by altered splicing may thus affect the substrate binding of ASB10 [23]. Based on an in silico
analysis of exonic splice enhancer sites, we assume that the effect of the p.Ala290Ala variant
may be subtle as the affinity for SRp55 is predicted to be reduced by approximately 40%, while
the splice enhancer (SF2/ASF) site affected by the p.Thr255Thr variant was completely lost. In
a survey by Chen et al it has been observed that both nonsynonymous and synonymous poly-
morphisms have an equal probability of their association with the disease (1.46% versus 1.26%
respectively) [24].
Three rare nonsynonymous variants were analyzed in family members, and did not segre-
gate with the disease in these families. The ASB10 protein is expressed in the retina, the retinal
ganglion cells, the trabecular meshwork, and the ciliary body. The ciliary body is involved in
the production of aqueous humor, and the trabecular meshwork plays a phagocytic role to
clear and regulate the outflow of aqueous humor. In the study of Pasutto et al, silencing of the
ASB10 gene was shown to lead to a higher resistance in the outflow of aqueous humor in a per-
fused segment organ culture [17]. Recently, evidence has also been provided for the involve-
ment of ASB10 in the ubiquitin-mediated degradation pathways in trabecular meshwork cells
[23].
In summary, the current study demonstrates that variants in ASB10 are significantly associ-
ated with POAG in the Pakistani population. The current case-control study had 84% power to
confirm the association. This study replicates the previous findings that sequence variants in
the ASB10 gene may act as a risk factor for glaucoma. Further studies in other populations are
required to better understand the role of ASB10 gene variants in glaucoma.
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